Cytek Biosciences (CTKB) Net Margin (2020 - 2026)
Cytek Biosciences (CTKB) reported Net Margin of 42.75% for Q1 2026, down 1524.0% on a YoY basis from 3.0% in Q1 2025, and up 39.73% quarter-over-quarter from 70.93% in Q4 2025.
Cytek Biosciences (CTKB) Net Margin (2020 - 2026) Analysis & Trends
Cytek Biosciences has reported Net Margin for 7 years, with the latest figure at 42.75% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 1524.0% year-over-year to 42.75%; the trailing twelve-month figure through Mar 2026 stood at 36.25% (down 3054.0% YoY), and the FY2025 full-year result was 33.02%, down 3002.0% from the prior year.
- Net Margin for Q1 2026 stood at 42.75%, up from 70.93% in the prior quarter.
- The five-year high for Net Margin was 16.78% in Q4 2024, with the low at 70.93% in Q4 2025.
- Historically, Net Margin has averaged 12.26% across 5 years, with a median of 10.48% in 2025.
- Annual changes were most pronounced in 2024 — Net Margin jumped 1528 bps — and 2025, when it sank 8771 bps.
- Cytek Biosciences' Net Margin stood at 7.3% in 2022, then gained by 29 bps to 9.45% in 2023, then surged by 78 bps to 16.78% in 2024, then sank by 523 bps to 70.93% in 2025, then jumped by 40 bps to 42.75% in 2026.
- The last three Net Margin figures came in at 42.75% (Q1 2026), 70.93% (Q4 2025), and 10.48% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Cytek Biosciences | - | - | 21.25 Mn | -42.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.75% |
| Dec 31, 2025 | -70.93% |
| Sep 30, 2025 | -10.48% |
| Jun 30, 2025 | -12.24% |
| Mar 31, 2025 | -27.50% |
| Dec 31, 2024 | 16.78% |
| Sep 30, 2024 | 1.83% |
| Jun 30, 2024 | -22.38% |
| Mar 31, 2024 | -13.75% |
| Dec 31, 2023 | 9.45% |
| Sep 30, 2023 | -13.45% |
| Jun 30, 2023 | -8.83% |
| Mar 31, 2023 | -18.35% |
| Dec 31, 2022 | 7.30% |
| Sep 30, 2022 | 4.12% |
| Jun 30, 2022 | -1.49% |
| Mar 31, 2022 | -5.76% |
| Sep 30, 2021 | 1.01% |
| Mar 31, 2021 | 0.42% |
| Dec 31, 2020 | -0.93% |